Caza secures funding 24/05/2013
US-focused Caza Oil & Gas (LON: CAZA) has secured funding from investment fund the Apollo Investment Corporation.
Nervous disorders drug developer Neuropharm plans to float on AIM with a £20 million placing at 127p.
West Coast Capital, the investment vehicle of retail and property entrepreneur Tom Hunter, is among the backers of 12-year-old Neuropharm, which has received fast-track development status from the US Food & Drugs Administration to use Prozac ingredient fluoxetine to treat autistic spectrum disorder. As nominated adviser and broker, South African-owned Investec Investment Banking is handling the placing for Neuropharm, steered by chief executive officer Robert Mansfield and chief scientific officer Dr Mike Snape.
A successful float will put a value of around £40 million on the company, whose declared strategy is to work with clinicians and patient groups to develop ‘tailored medicines for disorders of the central nervous system’. Neuropharm plans to market its products itself in the USA and out-license them elsewhere. It hopes to spend some of the placing proceeds on other programmes.

1. View our terms and conditions here
Advertisement
Live and pre recorded video & audio updates from companies on their latest news, results & AGMs through interviews and presentations. Find out more.
Gain instant access to some of the best-performing and fastest growing companies in the small cap arena. Sign up NOW!
The annual Directors' Pay on AIM Report is the most comprehensive review of directors' renumeration on AIM available. It's ideal for benchmarking your team's, your organisation's and your own salary. The full report is available to order in PDF format for £350 (+VAT). Order report here
This research provides a comprehensive overview of cash shells, companies that have become a significant feature on the Main Market, AIM and PLUS landscape. The full report (out June 2013) is now available to pre-order in PDF format for £295 (+VAT). Contact us for more info
This new report examines valuation metrics, cash balances and financial performance to provide dealmakers with all the tools they need to pinpoint undervalued companies on AIM. The full report is available to order in PDF format for £295 (+VAT). Order report here
Informative features and research on fast-growing companies, with AIM market and small cap tips, news on growth stocks, penny shares and junior stock market companies. Regular share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
US-focused Caza Oil & Gas (LON: CAZA) has secured funding from investment fund the Apollo Investment Corporation.
US shale oil venture Nighthawk Energy (AIM: HAWK) has found oil at the Big Sky 4-11 well in Colorado.
Software outsourcing specialist Quindell Portfolio (LON:QPP) has signed a five-year deal with a UK motor insurer, initially worth £3.5 million.
US-focused oil and gas explorer Magnolia Petroleum (LON:MAGP) has decided to participate in another 11 wells across North Dakota and Oklahoma.
Supplier of computing platforms for gaming and slot machines Quixant (LON:QXT) has joined London's junior market.
North Sea-focused Xcite Energy (LON:XER) will sell off data worth US$15 million (£9.9 million) regarding its Bentley 9/03b-6, 6Z well.